Utah Medical Products
UTMD
90 hedge funds and large institutions have $237M invested in Utah Medical Products in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 37 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
3% more funds holding
Funds holding: 87 → 90 (+3)
0.11% more ownership
Funds ownership: 70.05% → 70.16% (+0.11%)
1% less capital invested
Capital invested by funds: $241M → $237M (-$3.55M)
11% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Penn Mutual Asset Management
Conshohocken,
Pennsylvania
|
+$1.54M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.16M |
| 3 |
Millennium Management
New York
|
+$773K |
| 4 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$580K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$546K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$2.54M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$822K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$479K |
| 4 |
MDCM
Morgan Dempsey Capital Management
Menomonee Falls,
Wisconsin
|
-$471K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$467K |
UTMD Hedge Fund Activity: Q2 2023 in Review
90 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q2 2023, worth a combined $237M — down 1.5% from $241M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new UTMD positions and 3 closed out — a net gain of 3 holders — while 33 added to existing stakes and 37 trimmed.
The largest buyer was Penn Mutual Asset Management, adding an estimated $1.54M. The largest seller was JP Morgan Chase, cutting an estimated $2.54M.
- 90 institutional investors held Utah Medical Products (UTMD) as of Q2 2023, up from 87 in Q1 2023.
- Funds reported $237M of Utah Medical Products stock for Q2 2023, down 1.5% quarter-over-quarter.
- 6 funds opened new Utah Medical Products positions in Q2 2023 and 3 closed out, a net change of +3 holders.
- The largest Utah Medical Products buyer in Q2 2023 was Penn Mutual Asset Management, an estimated $1.54M added.
- The largest Utah Medical Products seller in Q2 2023 was JP Morgan Chase, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2023.